Everolimus-Eluting Platinum Chromium Coronary Stent System
Excellent Safety and Performance with Promus PtCr EES1
- Over 10,000 Patients Studied
- Over 3 Million Implanted
The Promus PREMIERTM Stent is the newest member of the PROMUSTM family, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.
PLATINUM Diversity Study
Increasing Diversity in Clinical TrialsLearn why